医学
激素疗法
队列
并发症
激素
队列研究
激素疗法
内科学
风险评估
病例对照研究
重症监护医学
随机对照试验
临床试验
外科
回顾性队列研究
梅德林
作者
V. B. PATEL,Joseph D. Quick,Shannon S. Wu,Rachel Schafer,R’ay Fodor,Sarah N. Bishop,Raffi Gurunian,Stephen L. Bernard,Risal S. Djohan,Graham S. Schwarz
标识
DOI:10.1097/prs.0000000000012741
摘要
BACKGROUND: Hormonal therapy (HT) has become a mainstay in the treatment of receptor-positive breast cancers. There have been conflicting reports regarding the effects of HT after autologous breast reconstruction (ABR), with some reports suggesting that patients on HT have a higher risk of complications and flap failure, whereas other studies bolster the perioperative safety of HT. Here, the authors present a matched cohort analysis to determine whether HT affects outcomes following ABR. METHODS: A retrospective review was conducted on patients undergoing ABR between 2016 and 2020. Patients were split into 2 cohorts: those on HT and those not on hormonal therapy (NH), based on a 1:1 propensity matching using variables known to be risk factors for complications after deep inferior epigastric perforator flap reconstruction, including body mass index, smoking, timing of reconstruction, mastectomy indication, and history of radiation and diabetes. RESULTS: Eighty-five patients were matched into the HT and NH cohorts. Overall, patients in the HT cohort were significantly more likely to develop a complication (HT: 28% versus NH: 15%; P = 0.04). The incidence of intraoperative thrombosis was similar between the cohorts, as was the incidence of postoperative total flap loss. Patients in the HT cohort had a significantly increased risk of venous thromboembolism than those in the NH cohort (HT: 7.0% versus NH: 0%; P = 0.03). CONCLUSIONS: This is the first study examining the effects of preoperative HT on ABR, with matched cohorts to control for comorbidities. Patients in the HT cohort had a significantly higher risk of complications and venous thromboembolic events, suggesting that they should discontinue HT before surgery.
科研通智能强力驱动
Strongly Powered by AbleSci AI